Megagod-NT Tablet contains a combination of Pregabalin 75 mg and Nortriptyline 10 mg, formulated for the management of neuropathic pain and certain chronic pain conditions. Pregabalin, an anticonvulsant and analgesic agent, acts by modulating calcium channels in the central nervous system, thereby reducing neurotransmitter release and alleviating neuropathic pain symptoms. Nortriptyline, a tricyclic antidepressant, contributes to pain relief through inhibition of norepinephrine and serotonin reuptake, enhancing descending inhibitory pain pathways. The synergistic action of these two agents provides effective analgesia in conditions such as diabetic neuropathy, postherpetic neuralgia, and fibromyalgia. Megagod-NT is indicated for patients who require combination therapy for improved pain control when monotherapy is insufficient. It should be used under medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with a history of cardiac arrhythmias, hepatic or renal impairment, and those taking other central nervous system depressants. Pregnant or breastfeeding women should consult a healthcare professional prior to use. Megagod-NT Tablet offers a targeted therapeutic option for complex neuropathic pain management, enhancing patient quality of life through multimodal pharmacotherapy.